These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 2450068
1. Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin. Tsuzuki K, Yokosawa N, Syuto B, Ohishi I, Fujii N, Kimura K, Oguma K. Infect Immun; 1988 Apr; 56(4):898-902. PubMed ID: 2450068 [Abstract] [Full Text] [Related]
2. Sequence homology between tetanus and botulinum toxins detected by an antipeptide antibody. Halpern JL, Smith LA, Seamon KB, Groover KA, Habig WH. Infect Immun; 1989 Jan; 57(1):18-22. PubMed ID: 2909486 [Abstract] [Full Text] [Related]
3. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin. Kozaki S, Kamata Y, Nagai T, Ogasawara J, Sakaguchi G. Infect Immun; 1986 Jun; 52(3):786-91. PubMed ID: 2423459 [Abstract] [Full Text] [Related]
4. Cloning and whole nucleotide sequence of the gene for the light chain component of botulinum type E toxin from Clostridium butyricum strain BL6340 and Clostridium botulinum type E strain Mashike. Fujii N, Kimura K, Yashiki T, Tsuzuki K, Moriishi K, Yokosawa N, Syuto B, Oguma K. Microbiol Immunol; 1992 Jun; 36(3):213-20. PubMed ID: 1602997 [Abstract] [Full Text] [Related]
5. Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies. Kubota T, Watanabe T, Yokosawa N, Tsuzuki K, Indoh T, Moriishi K, Sanda K, Maki Y, Inoue K, Fujii N. Appl Environ Microbiol; 1997 Apr; 63(4):1214-8. PubMed ID: 9097417 [Abstract] [Full Text] [Related]
6. Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum. Oguma K, Agui T, Syuto B, Kimura K, Iida H, Kubo S. Infect Immun; 1982 Oct; 38(1):14-20. PubMed ID: 6183207 [Abstract] [Full Text] [Related]
7. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains. Oguma K, Syuto B, Iida H, Kubo S. Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231 [Abstract] [Full Text] [Related]
8. Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies. Oguma K, Murayama S, Syuto B, Iida H, Kubo S. Infect Immun; 1984 Feb; 43(2):584-8. PubMed ID: 6198281 [Abstract] [Full Text] [Related]
9. Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes. Murayama S, Syuto B, Oguma K, Iida H, Kubo S. Eur J Biochem; 1984 Aug 01; 142(3):487-92. PubMed ID: 6468375 [Abstract] [Full Text] [Related]
10. Molecular diversity of neurotoxins from Clostridium botulinum type D strains. Moriishi K, Syuto B, Kubo S, Oguma K. Infect Immun; 1989 Sep 01; 57(9):2886-91. PubMed ID: 2668193 [Abstract] [Full Text] [Related]
11. Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains. Ochanda JO, Syuto B, Oguma K, Iida H, Kubo S. Appl Environ Microbiol; 1984 Jun 01; 47(6):1319-22. PubMed ID: 6204594 [Abstract] [Full Text] [Related]
12. Immuno-crossreactivity between botulinum neurotoxin type C1 or D and exoenzyme C3. Toratani S, Yokosawa N, Yokosawa H, Ishii S, Oguma K. FEBS Lett; 1989 Jul 31; 252(1-2):83-7. PubMed ID: 2474453 [Abstract] [Full Text] [Related]
13. Binding and cytotoxic effects of Clostridium botulinum type A, C1 and E toxins in primary neuron cultures from foetal mouse brains. Kurokawa Y, Oguma K, Yokosawa N, Syuto B, Fukatsu R, Yamashita I. J Gen Microbiol; 1987 Sep 31; 133(9):2647-57. PubMed ID: 3329217 [Abstract] [Full Text] [Related]
14. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA. Notermans S, Dufrenne J, Kozaki S. Jpn J Med Sci Biol; 1982 Sep 31; 35(5-6):203-11. PubMed ID: 6761472 [Abstract] [Full Text] [Related]
17. Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids. Kozaki S, Ogasawara J, Shimote Y, Kamata Y, Sakaguchi G. Infect Immun; 1987 Dec 31; 55(12):3051-6. PubMed ID: 2824382 [Abstract] [Full Text] [Related]
20. Cloning of the structural gene for Clostridium botulinum type C1 toxin and whole nucleotide sequence of its light chain component. Kimura K, Fujii N, Tsuzuki K, Murakami T, Indoh T, Yokosawa N, Oguma K. Appl Environ Microbiol; 1991 Apr 31; 57(4):1168-72. PubMed ID: 2059039 [Abstract] [Full Text] [Related] Page: [Next] [New Search]